
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-04-29 10:10:20Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 29 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 4.98% Gain — Buyers Queue, Sellers Absent
2026-04-21 11:00:05At Rs 62.34, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Krebs Biochemicals & Industries Ltd locked at its upper circuit of 4.98% on 21 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-04-18 10:10:14Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read full news article
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-04-07 10:10:18Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 07 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Read full news article
Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent
2026-04-07 10:00:07At Rs 68.58, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Krebs Biochemicals & Industries Ltd locked at its upper circuit of 20% on 6 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 20% Gain — Buyers Queue, Sellers Absent
2026-04-06 11:00:05At Rs 57.15, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Krebs Biochemicals & Industries Ltd locked at its upper circuit of 20% on 6 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low of Rs 40.92 as Sell-Off Deepens
2026-03-30 13:08:35For the third consecutive session, Krebs Biochemicals & Industries Ltd has seen its share price decline sharply, hitting a fresh 52-week low of Rs 40.92 on 30 Mar 2026. This marks an 11.6% drop over three days, underscoring persistent selling pressure amid broader market weakness.
Read full news article
Krebs Biochemicals & Industries Ltd Falls to 52-Week Low of Rs 46.54 as Sell-Off Deepens
2026-03-27 10:49:17For the second consecutive session, Krebs Biochemicals & Industries Ltd has declined further, hitting a fresh 52-week low of Rs 46.54 on 27 Mar 2026, extending its downward trajectory amid broader market weakness.
Read full news article
Krebs Biochemicals & Industries Ltd is Rated Strong Sell
2026-03-27 10:10:15Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleClarification On Price Movement
10-Apr-2026 | Source : BSEClarification on price movement
Clarification Sought from Krebs Biochemicals & Industries Ltd
08-Apr-2026 | Source : BSEThe Exchange has sought clarification from Krebs Biochemicals & Industries Ltd on April 8 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.
The reply is awaited.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
07-Apr-2026 | Source : BSEThe Company has enclosing herewith certificate received from RTA under reg 74 (5) of SEBI DP Regulations 2018 for the quarter ended 31.03.2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Krebs Biochemicals & Industries Ltd has announced 21:100 rights issue, ex-date: 31 Jan 19






